Skip to content

Therapeutic effect of digoxin on patients with pulmonary hypertension induced by peritoneal dialysis

Therapeutic effect of digoxin on patients with pulmonary hypertension induced by peritoneal dialysis

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023017
Enrollment
Unknown
Registered
2019-05-07
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peritoneal dialysis

Interventions

Case Series:Digoxin

Sponsors

Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Gender, age, and race are not limited; 2) Those who meet the following two conditions: chronic nephritis peritoneal dialysis patients, while cardiac ultrasound or cardiac mri suggest pulmonary hypertension; 3) Volunteer to participate in the project and sign the informed consent form (patients <18 years of age must be signed and approved by the legal guardian).

Exclusion criteria

Exclusion criteria: 1) Those who have received sildenafil or other types of pulmonary arterial pressure drugs in the past 3 months; 2) Hb is less than 85g / l, combined with serious diseases or acute infections; 3) Malignant tumors.

Design outcomes

Primary

MeasureTime frame
Pulmonary artery pressure;

Countries

China

Contacts

Public ContactAo Xiang

Department of Nephrology, Xiangya Hospital, Central South University

2403980692@qq.com+86 13975806025

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026